NCT01781403View on ClinicalTrials.gov

Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 10, 2013

Primary Completion Date

September 3, 2014

Study Completion Date

May 4, 2016

Conditions
Rectal Cancer
Interventions
DRUG

Temozolomide

Preoperative chemoradiotherapy with fixed dose of capecitabine and temozolomide, the dose of temozolomide will be escalated for finding MTD and RD.

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER